{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:33:14Z","timestamp":1794947594522,"version":"4.9.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700553"],"award-info":[{"award-number":["81700553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang basic public welfare research program","award":["LGF20H030008"],"award-info":[{"award-number":["LGF20H030008"]}]},{"name":"Independent Fund of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.<\/jats:p>","DOI":"10.1186\/s13287-020-01895-1","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T09:03:57Z","timestamp":1599123837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury"],"prefix":"10.1186","volume":"11","author":[{"given":"Chenxia","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongling","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"6","key":"1895_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00109-018-1638-5","volume":"96","author":"CA Lee","year":"2018","unstructured":"Lee CA, Sinha S, Fitzpatrick E, Dhawan A. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. J Mol Med (Berl). 2018;96(6):469\u201381.","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"1895_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.21037\/atm.2020.03.218","volume":"8","author":"S Zhang","year":"2020","unstructured":"Zhang S, Yang Y, Fan L, Zhang F, Li L. The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. Ann Transl Med. 2020;8(8):565.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1895_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"5","key":"1895_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrgastro.2014.44","volume":"11","author":"SJ Forbes","year":"2014","unstructured":"Forbes SJ, Alison MR. Regenerative medicine. Knocking on the door to successful hepatocyte transplantation. Nat Rev Gastroenterol Hepatol. 2014;11(5):277\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"7","key":"1895_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/14779072.2019.1635012","volume":"17","author":"M Miceli","year":"2019","unstructured":"Miceli M, Baldi D, Cavaliere C, Soricelli A, Salvatore M, Napoli C. Peripheral artery disease: the new frontiers of imaging techniques to evaluate the evolution of regenerative medicine. Expert Rev Cardiovasc Ther. 2019;17(7):511\u201332.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"1895_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell."},{"issue":"1","key":"1895_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nbt1374","volume":"26","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26(1):101\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1895_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-019-1310-1","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Li L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther. 2019;10(1):199.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"1895_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/gutjnl-2015-311146","volume":"66","author":"D Shi","year":"2017","unstructured":"Shi D, Zhang J, Zhou Q, Xin J, Jiang J, Jiang L, Wu T, Li J, Ding W, Sun S, Zhou N, Zhang L, Jin L, Hao S, Chen P, Cao H, Li M, Li L, Chen X. Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs. Gut. 2017;66(5):955\u201364.","journal-title":"Gut."},{"issue":"3","key":"1895_CR10","doi-asserted-by":"publisher","first-page":"e2141","DOI":"10.1038\/cddis.2016.1","volume":"7","author":"C Hu","year":"2016","unstructured":"Hu C, Cao H, Pan X, Li J, He J, Pan Q, Xin J, Yu X, Wang Y, Zhu D, Li L. Adipogenic placenta-derived mesenchymal stem cells are not lineage restricted by withdrawing extrinsic factors: developing a novel visual angle in stem cell biology. Cell Death Dis. 2016;7(3):e2141.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1895_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/cells1041061","volume":"1","author":"A Lindenmair","year":"2012","unstructured":"Lindenmair A, Hatlapatka T, Kollwig G, Hennerbichler S, Gabriel C, Wolbank S, Redl H, Kasper C. Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells. 2012;1(4):1061\u201388.","journal-title":"Cells."},{"issue":"1","key":"1895_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13287-019-1503-7","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen L, Qu J, Cheng T, Chen X, Xiang C. Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases. Stem Cell Res Ther. 2019;10(1):406.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"1895_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy."},{"issue":"1","key":"1895_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36\u201345.","journal-title":"Int J Med Sci"},{"issue":"1","key":"1895_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc.2008.1.1.1","volume":"1","author":"A Kurtz","year":"2008","unstructured":"Kurtz A. Mesenchymal stem cell delivery routes and fate. Int J Stem Cells. 2008;1(1):1\u20137.","journal-title":"Int J Stem Cells"},{"issue":"7","key":"1895_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","volume":"15","author":"L Barkholt","year":"2013","unstructured":"Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, B\u00fcscher D, Fibbe W, Foussat A, Kwa M, Lantz O, Ma\u010diulaitis R, Palom\u00e4ki T, Schneider CK, Senseb\u00e9 L, Tachdjian G, Tarte K, Tosca L, Salmikangas P. Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy. 2013;15(7):753\u20139.","journal-title":"Cytotherapy."},{"issue":"5","key":"1895_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/14653249.2010.507330","volume":"12","author":"DJ Prockop","year":"2010","unstructured":"Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L, Keating A. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010;12(5):576\u20138.","journal-title":"Cytotherapy."},{"issue":"4","key":"1895_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","volume":"24","author":"M Miura","year":"2006","unstructured":"Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006;24(4):1095\u2013103.","journal-title":"Stem Cells"},{"issue":"2","key":"1895_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1634\/stemcells.2004-0331","volume":"24","author":"PA Sotiropoulou","year":"2006","unstructured":"Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24(2):462\u201371.","journal-title":"Stem Cells"},{"issue":"3","key":"1895_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","volume":"77","author":"D Furlani","year":"2009","unstructured":"Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, Wang W, Yerebakan C, Li W, Gaebel R, Li RK, Vollmar B, Steinhoff G, Ma N. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77(3):370\u20136.","journal-title":"Microvasc Res"},{"key":"1895_CR21","doi-asserted-by":"crossref","unstructured":"Eggenhofer E, Luk F, Dahlke MH, Hoogduijn MJ. The life and fate of mesenchymal stem cells. Front Immunol. 2014;5:148.","DOI":"10.3389\/fimmu.2014.00148"},{"key":"1895_CR22","doi-asserted-by":"crossref","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, Baan CC, Dahlke MH, Hoogduijn MJ. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3(297).","DOI":"10.3389\/fimmu.2012.00297"},{"issue":"7","key":"1895_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.21037\/atm.2017.03.50","volume":"5","author":"L Beer","year":"2017","unstructured":"Beer L, Mildner M, Ankersmit HJ. Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science. Ann Transl Med. 2017;5(7):170.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1895_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/156652312802083594","volume":"12","author":"AJ O'Loughlin","year":"2012","unstructured":"O'Loughlin AJ, Woffindale CA, Wood MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther. 2012;12(4):262\u201374.","journal-title":"Curr Gene Ther"},{"key":"1895_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.exer.2016.06.022","volume":"149","author":"MA Bermudez","year":"2016","unstructured":"Bermudez MA, Sendon-Lago J, Seoane S, Eiro N, Gonzalez F, Saa J, Vizoso F, Perez-Fernandez R. Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis. Exp Eye Res. 2016;149:84\u201392.","journal-title":"Exp Eye Res"},{"issue":"13\u201314","key":"1895_CR26","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1089\/ten.tea.2011.0325","volume":"18","author":"M Osugi","year":"2012","unstructured":"Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H, Ueda M. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A. 2012;18(13\u201314):1479\u201389.","journal-title":"Tissue Eng Part A"},{"issue":"1","key":"1895_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10528-018-9869-2","volume":"57","author":"X Yang","year":"2019","unstructured":"Yang X, He C, Zhu L, Zhao W, Li S, Xia C, Xu C. Comparative analysis of regulatory role of notch signaling pathway in 8 types liver cell during liver regeneration. Biochem Genet. 2019;57(1):1\u201319.","journal-title":"Biochem Genet"},{"issue":"1","key":"1895_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-019-1225-x","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Wu D, Li L. Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury. Stem Cell Res Ther. 2019;10(1):120.","journal-title":"Stem Cell Res Ther"},{"issue":"23","key":"1895_CR29","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","volume":"20","author":"WC Zhou","year":"2014","unstructured":"Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20(23):7312\u201324.","journal-title":"World J Gastroenterol"},{"key":"1895_CR30","doi-asserted-by":"crossref","unstructured":"Mafanda EK, Kandhi R, Bobbala D, Khan MGM, Nandi M, Menendez A, Ramanathan S, Ilangumaran S. Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis. Cytokine. 2019;124:154501.","DOI":"10.1016\/j.cyto.2018.07.032"},{"issue":"5","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/hep.20703","volume":"41","author":"J Polson","year":"2005","unstructured":"Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41(5):1179\u201397.","journal-title":"Hepatology."},{"issue":"4","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/hep.30056","volume":"68","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, Szabo G, Tandon P, Olson J, Karvellas C, Gustot T, Lai JC, Wong F. Acute-on-chronic liver failure: getting ready for prime time? Hepatology. 2018;68(4):1621\u201332.","journal-title":"Hepatology."},{"issue":"3","key":"1895_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/s-2003-42639","volume":"23","author":"SM Riordan","year":"2003","unstructured":"Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis. 2003;23(3):203\u201315.","journal-title":"Semin Liver Dis"},{"key":"1895_CR34","first-page":"101","volume":"93","author":"GK Michalopoulos","year":"2005","unstructured":"Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Eng Biotechnol. 2005;93:101\u201334.","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"1895_CR35","unstructured":"Jaeschke H and Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia\/reperfusion injury. (0016\u20135085 (Print))."},{"issue":"5","key":"1895_CR36","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology. 2013;57(5):1773\u201383.","journal-title":"Hepatology."},{"issue":"1","key":"1895_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4161\/auto.2229","volume":"2","author":"S Rodriguez-Enriquez","year":"2006","unstructured":"Rodriguez-Enriquez S, Kim I, Currin RT, Lemasters JJ. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy. 2006;2(1):39\u201346.","journal-title":"Autophagy."},{"issue":"7242","key":"1895_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135.","journal-title":"Nature."},{"issue":"2 Suppl 1","key":"1895_CR39","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1002\/hep.21062","volume":"43","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology. 2006;43(2 Suppl 1):S31\u201344.","journal-title":"Hepatology."},{"issue":"4","key":"1895_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495\u2013516.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"1895_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1439-0264.2002.00398.x","volume":"31","author":"S Van Cruchten","year":"2002","unstructured":"Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 2002;31(4):214\u201323.","journal-title":"Anat Histol Embryol"},{"issue":"1","key":"1895_CR42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/hep.24305","volume":"54","author":"H Hikita","year":"2011","unstructured":"Hikita H, Takehara T, Kodama T, Shimizu S, Shigekawa M, Hosui A, Miyagi T, Tatsumi T, Ishida H, Li W, Kanto T, Hiramatsu N, Tsujimoto Y, Hayashi N. Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak\/Bax-deficient mice. Hepatology. 2011;54(1):240\u201351.","journal-title":"Hepatology."},{"issue":"1","key":"1895_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/019262339702500116","volume":"25","author":"BF Trump","year":"1997","unstructured":"Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol. 1997;25(1):82\u20138.","journal-title":"Toxicol Pathol"},{"issue":"12","key":"1895_CR44","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018;15(12):738\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1895_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymeth.2013.06.001","volume":"61","author":"SJ Martin","year":"2013","unstructured":"Martin SJ, Henry CM. Distinguishing between apoptosis, necrosis, necroptosis and other cell death modalities. Methods. 2013;61(2):87\u20139.","journal-title":"Methods."},{"issue":"21","key":"1895_CR46","doi-asserted-by":"publisher","first-page":"15342","DOI":"10.1074\/jbc.M112.439547","volume":"288","author":"C Sanz-Garcia","year":"2013","unstructured":"Sanz-Garcia C, Ferrer-Mayorga G, Gonzalez-Rodriguez A, Valverde AM, Martin-Duce A, Velasco-Martin JP, Regadera J, Fernandez M, Alemany S. Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot\/tpl2. J Biol Chem. 2013;288(21):15342\u201351.","journal-title":"J Biol Chem"},{"key":"1895_CR47","doi-asserted-by":"crossref","unstructured":"Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260.","DOI":"10.1186\/s12967-014-0260-8"},{"issue":"1","key":"1895_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.201504136","volume":"211","author":"V Hyenne","year":"2015","unstructured":"Hyenne V, Apaydin A, Rodriguez D, Spiegelhalter C, Hoff-Yoessle S, Diem M, Tak S, Lefebvre O, Schwab Y, Goetz JG, Labouesse M. RAL-1 controls multivesicular body biogenesis and exosome secretion. J Cell Biol. 2015;211(1):27\u201337.","journal-title":"J Cell Biol"},{"key":"1895_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ymeth.2015.04.015","volume":"87","author":"MF Peterson","year":"2015","unstructured":"Peterson MF, Otoc N, Sethi JK, Gupta A, Antes TJ. Integrated systems for exosome investigation. Methods. 2015;87:31\u201345.","journal-title":"Methods."},{"key":"1895_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.semcdb.2015.03.001","volume":"40","author":"RC Lai","year":"2015","unstructured":"Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82\u20138.","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"1895_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2217\/rme.11.35","volume":"6","author":"RC Lai","year":"2011","unstructured":"Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011;6(4):481\u201392.","journal-title":"Regen Med"},{"issue":"32","key":"1895_CR52","doi-asserted-by":"publisher","first-page":"22258","DOI":"10.1074\/jbc.M114.588046","volume":"289","author":"T Tian","year":"2014","unstructured":"Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, Xiao ZD. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289(32):22258\u201367.","journal-title":"J Biol Chem"},{"key":"1895_CR53","doi-asserted-by":"crossref","unstructured":"Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3.","DOI":"10.3402\/jev.v3.24641"},{"issue":"49","key":"1895_CR54","doi-asserted-by":"publisher","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","volume":"284","author":"I Parolini","year":"2009","unstructured":"Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211\u201322.","journal-title":"J Biol Chem"},{"issue":"2","key":"1895_CR55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/pr200682z","volume":"11","author":"HS Kim","year":"2012","unstructured":"Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW, Jung JW, Hwang D, Kim KP, Kim DW. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2012;11(2):839\u201349.","journal-title":"J Proteome Res"},{"issue":"2","key":"1895_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12015-016-9715-z","volume":"13","author":"AB Angulski","year":"2017","unstructured":"Angulski AB, Capriglione LG, Batista M, Marcon BH, Senegaglia AC, Stimamiglio MA, Correa A. The protein content of extracellular vesicles derived from expanded human umbilical cord blood-derived CD133(+) and human bone marrow-derived mesenchymal stem cells partially explains why both sources are advantageous for regenerative medicine. Stem Cell Rev Rep. 2017;13(2):244\u201357.","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"1895_CR57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/stem.2298","volume":"34","author":"JD Anderson","year":"2016","unstructured":"Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling. Stem Cells. 2016;34(3):601\u201313.","journal-title":"Stem Cells"},{"issue":"9","key":"1895_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s12276-018-0142-x","volume":"50","author":"A La Greca","year":"2018","unstructured":"La Greca A, Solari C, Furmento V, Lombardi A, Biani MC, Aban C, Moro L, Garc\u00eda M, Guberman AS, Sevlever GE, Miriuka SG, Luzzani C. Extracellular vesicles from pluripotent stem cell-derived mesenchymal stem cells acquire a stromal modulatory proteomic pattern during differentiation. Exp Mol Med. 2018;50(9):119.","journal-title":"Exp Mol Med"},{"key":"1895_CR59","doi-asserted-by":"publisher","first-page":"971907","DOI":"10.1155\/2012\/971907","volume":"2012","author":"RC Lai","year":"2012","unstructured":"Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, Choo A, Lim SK. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics. 2012;2012:971907.","journal-title":"Int J Proteomics"},{"key":"1895_CR60","doi-asserted-by":"publisher","first-page":"36120","DOI":"10.1038\/srep36120","volume":"6","author":"A Eirin","year":"2016","unstructured":"Eirin A, Zhu XY, Puranik AS, Woollard JR, Tang H, Dasari S, Lerman A, van Wijnen AJ, Lerman LO. Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem\/stromal cells. Sci Rep. 2016;6:36120.","journal-title":"Sci Rep"},{"issue":"7","key":"1895_CR61","doi-asserted-by":"publisher","first-page":"e68451","DOI":"10.1371\/journal.pone.0068451","volume":"8","author":"C Salomon","year":"2013","unstructured":"Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, Rice GE. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One. 2013;8(7):e68451.","journal-title":"PLoS One"},{"key":"1895_CR62","doi-asserted-by":"crossref","unstructured":"Kilpinen L, Impola U, Sankkila L, Ritamo I, Aatonen M, Kilpinen S, Tuimala J, Valmu L, Levijoki J, Finckenberg P, Siljander P, Kankuri E, Mervaala E, Laitinen S. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell Vesicles. 2013;2.","DOI":"10.3402\/jev.v2i0.21927"},{"issue":"22","key":"1895_CR63","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.7150\/thno.28021","volume":"8","author":"LP Zhu","year":"2018","unstructured":"Zhu LP, Tian T, Wang JY, He JN, Chen T, Pan M, Xu L, Zhang HX, Qiu XT, Li CC, Wang KK, Shen H, Zhang GG, Bai YP. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8(22):6163\u201377.","journal-title":"Theranostics."},{"key":"1895_CR64","doi-asserted-by":"crossref","first-page":"1929536","DOI":"10.1155\/2016\/1929536","volume":"2016","author":"B Zhang","year":"2016","unstructured":"Zhang B, Shen L, Shi H, Pan Z, Wu L, Yan Y, Zhang X, Mao F, Qian H, Xu W. Exosomes from human umbilical cord mesenchymal stem cells: identification, purification, and biological characteristics. Stem Cells Int. 2016;2016:1929536.","journal-title":"Stem Cells Int"},{"key":"1895_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2019.07.021","volume":"308","author":"XX Yang","year":"2019","unstructured":"Yang XX, Sun C, Wang L, Guo XL. New insight into isolation, identification techniques and medical applications of exosomes. J Control Release. 2019;308:119\u201329.","journal-title":"J Control Release"},{"issue":"7","key":"1895_CR66","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/jth.12602","volume":"12","author":"E van der Pol","year":"2014","unstructured":"van der Pol E, Coumans FA, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, Sturk A, van Leeuwen TG, Nieuwland R. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12(7):1182\u201392.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1895_CR67","doi-asserted-by":"publisher","first-page":"e0144678","DOI":"10.1371\/journal.pone.0144678","volume":"11","author":"KM Danielson","year":"2016","unstructured":"Danielson KM, Estanislau J, Tigges J, Toxavidis V, Camacho V, Felton EJ, Khoory J, Kreimer S, Ivanov AR, Mantel PY, Jones J, Akuthota P, Das S, Ghiran I. Diurnal variations of circulating extracellular vesicles measured by nano flow cytometry. PLoS One. 2016;11(1):e0144678.","journal-title":"PLoS One"},{"issue":"12","key":"1895_CR68","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.bbamcr.2018.09.008","volume":"1865","author":"Z Nizamudeen","year":"2018","unstructured":"Nizamudeen Z, Markus R, Lodge R, Parmenter C, Platt M, Chakrabarti L, Sottile V. Rapid and accurate analysis of stem cell-derived extracellular vesicles with super resolution microscopy and live imaging. Biochim Biophys Acta Mol Cell Res. 2018;1865(12):1891\u2013900.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"10","key":"1895_CR69","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1373\/clinchem.2018.291963","volume":"64","author":"Y Kabe","year":"2018","unstructured":"Kabe Y, Suematsu M, Sakamoto S, Hirai M, Koike I, Hishiki T, Matsuda A, Hasegawa Y, Tsujita K, Ono M, Minegishi N, Hozawa A, Murakami Y, Kubo M, Itonaga M, Handa H. Development of a highly sensitive device for counting the number of disease-specific exosomes in human sera. Clin Chem. 2018;64(10):1463\u201373.","journal-title":"Clin Chem"},{"issue":"1","key":"1895_CR70","doi-asserted-by":"publisher","first-page":"1587567","DOI":"10.1080\/20013078.2019.1587567","volume":"8","author":"A G\u00f6rgens","year":"2019","unstructured":"G\u00f6rgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, Thalmann S, Welsh JA, Probst C, Guerin C, Boulanger CM, Jones JC, Hanenberg H, Erdbr\u00fcgger U, Lannigan J, Ricklefs FL, El-Andaloussi S, Giebel B. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019;8(1):1587567.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"1895_CR71","first-page":"113","volume":"32","author":"YS Chen","year":"2019","unstructured":"Chen YS, Lin EY, Chiou TW, Harn HJ. Exosomes in clinical trial and their production in compliance with good manufacturing practice. Ci Ji Yi Xue Za Zhi. 2019;32(2):113\u201320.","journal-title":"Ci Ji Yi Xue Za Zhi"},{"issue":"1","key":"1895_CR72","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"1895_CR73","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1600-0854.2009.00920.x","volume":"10","author":"S Stuffers","year":"2009","unstructured":"Stuffers S, Sem Wegner C, Stenmark H, Brech A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic. 2009;10(7):925\u201337.","journal-title":"Traffic."},{"issue":"8","key":"1895_CR74","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Th\u00e9ry C. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113(8):E968\u201377.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"R1","key":"1895_CR75","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1093\/hmg\/dds317","volume":"21","author":"Y Lee","year":"2012","unstructured":"Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21(R1):R125\u201334.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"1895_CR76","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"key":"1895_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fcvm.2017.00063","volume":"4","author":"GR Willis","year":"2017","unstructured":"Willis GR, Kourembanas S, Mitsialis SA. Toward exosome-based therapeutics: isolation, heterogeneity, and fit-for-purpose potency. Front Cardiovasc Med. 2017;4:63.","journal-title":"Front Cardiovasc Med"},{"key":"1895_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.omtm.2018.12.003","volume":"13","author":"N Pacienza","year":"2019","unstructured":"Pacienza N, Lee RH, Bae EH, Kim DK, Liu Q, Prockop DJ, Yannarelli G. In vitro macrophage assay predicts the in vivo anti-inflammatory potential of exosomes from human mesenchymal stromal cells. Mol Ther Methods Clin Dev. 2019;13:67\u201376.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"1895_CR79","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jrr\/rrv026","volume":"56","author":"YX Chen","year":"2015","unstructured":"Chen YX, Zeng ZC, Sun J, Zeng HY, Huang Y, Zhang ZY. Mesenchymal stem cell-conditioned medium prevents radiation-induced liver injury by inhibiting inflammation and protecting sinusoidal endothelial cells. J Radiat Res. 2015;56(4):700\u20138.","journal-title":"J Radiat Res"},{"issue":"2","key":"1895_CR80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jss.2013.02.009","volume":"183","author":"Z Du","year":"2013","unstructured":"Du Z, Wei C, Cheng K, Han B, Yan J, Zhang M, Peng C, Liu Y. Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. J Surg Res. 2013;183(2):907\u201315.","journal-title":"J Surg Res"},{"key":"1895_CR81","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","volume":"14","author":"B Huang","year":"2016","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga HZ, Wang D, Zhang K, Zhang H, Xue Z, Da Y, Zhang N, Hu Y, Yao Z, Qiao L, Gao F, Zhang R. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016;14:45.","journal-title":"J Transl Med"},{"issue":"1","key":"1895_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13770-018-0160-8","volume":"16","author":"YH Kim","year":"2019","unstructured":"Kim YH, Cho KA, Park M, Kim HS, Park JW, Woo SY, Ryu KH. Conditioned medium from tonsil-derived mesenchymal stem cells relieves CCl4-induced liver fibrosis in mice. Tissue Eng Regen Med. 2019;16(1):51\u20138.","journal-title":"Tissue Eng Regen Med"},{"key":"1895_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-016-0030-5","volume":"36","author":"R Tamura","year":"2016","unstructured":"Tamura R, Uemoto S, Tabata Y. Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model. Inflamm Regen. 2016;36:26.","journal-title":"Inflamm Regen"},{"issue":"2","key":"1895_CR84","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1159\/000480533","volume":"43","author":"Y Du","year":"2017","unstructured":"Du Y, Li D, Han C, Wu H, Xu L, Zhang M, Zhang J, Chen X. Exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect liver against hepatic ischemia\/ reperfusion injury via activating sphingosine kinase and sphingosine-1-phosphate signaling pathway. Cell Physiol Biochem. 2017;43(2):611\u201325.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"1895_CR85","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","volume":"508","author":"L Jiang","year":"2019","unstructured":"Jiang L, Zhang S, Hu H, Yang J, Wang X, Ma Y, Jiang J, Wang J, Zhong L, Chen M, Wang H, Hou Y, Zhu R, Zhang Q. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages. Biochem Biophys Res Commun. 2019;508(3):735\u201341.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1895_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13287-016-0453-6","volume":"8","author":"L Chen","year":"2017","unstructured":"Chen L, Xiang B, Wang X, Xiang C. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure. Stem Cell Res Ther. 2017;8(1):9.","journal-title":"Stem Cell Res Ther"},{"key":"1895_CR87","doi-asserted-by":"crossref","unstructured":"Jiang W, Tan Y, Cai M, Zhao T, Mao F, Zhang X, Xu W, Yan Z, Qian H, Yan Y. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect. Stem Cells Int. 2018;2018:6079642.","DOI":"10.1155\/2018\/6079642"},{"issue":"1","key":"1895_CR88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/beta-catenin pathway. Stem Cell Res Ther. 2019;10(1):98.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"1895_CR89","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, Xu W. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354.","journal-title":"Stem Cells Dev"},{"key":"1895_CR90","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ebiom.2018.08.054","volume":"36","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lou G, Li A, Zhang T, Qi J, Ye D, Zheng M, Chen Z. AMSC-derived exosomes alleviate lipopolysaccharide\/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP\/NLRP3 inflammasome activation in macrophages. EBioMed. 2018;36:140\u201350.","journal-title":"EBioMed"},{"issue":"2","key":"1895_CR91","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ymthe.2016.11.019","volume":"25","author":"Y Yan","year":"2017","unstructured":"Yan Y, Jiang W, Tan Y, Zou S, Zhang H, Mao F, Gong A, Qian H, Xu W. hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury. Mol Ther. 2017;25(2):465\u201379.","journal-title":"Mol Ther"},{"issue":"2","key":"1895_CR92","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/ten.teb.2009.0296","volume":"16","author":"R Das","year":"2010","unstructured":"Das R, Jahr H, van Osch GJ, Farrell E. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev. 2010;16(2):159\u201368.","journal-title":"Tissue Eng Part B Rev"},{"issue":"6","key":"1895_CR93","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2217\/rme.13.71","volume":"8","author":"KE Hawkins","year":"2013","unstructured":"Hawkins KE, Sharp TV, McKay TR. The role of hypoxia in stem cell potency and differentiation. Regen Med. 2013;8(6):771\u201382.","journal-title":"Regen Med"},{"issue":"3","key":"1895_CR94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.arcmed.2013.03.006","volume":"44","author":"AA Kiani","year":"2013","unstructured":"Kiani AA, Kazemi A, Halabian R, Mohammadipour M, Jahanian-Najafabadi A, Roudkenar MH. HIF-1alpha confers resistance to induced stress in bone marrow-derived mesenchymal stem cells. Arch Med Res. 2013;44(3):185\u201393.","journal-title":"Arch Med Res"},{"key":"1895_CR95","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/HMER.S196354","volume":"11","author":"A Temnov","year":"2019","unstructured":"Temnov A, Rogov K, Zhalimov V, Igor P, Pekov S, Bader A, Sklifas A, Giri S. The effect of a mesenchymal stem cell conditioned medium fraction on morphological characteristics of hepatocytes in acetaminophen-induced acute liver failure: a preliminary study. Hepat Med. 2019;11:89\u201396.","journal-title":"Hepat Med"},{"issue":"6","key":"1895_CR96","doi-asserted-by":"publisher","first-page":"816","DOI":"10.5966\/sctm.2015-0191","volume":"5","author":"SC Lee","year":"2016","unstructured":"Lee SC, Jeong HJ, Lee SK, Kim SJ. Hypoxic conditioned medium from human adipose-derived stem cells promotes mouse liver regeneration through JAK\/STAT3 signaling. Stem Cells Transl Med. 2016;5(6):816\u201325.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"1895_CR97","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s11033-019-04765-z","volume":"46","author":"AA Temnov","year":"2019","unstructured":"Temnov AA, Rogov KA, Sklifas AN, Klychnikova EV, Hartl M, Djinovic-Carugo K, Charnagalov A. Protective properties of the cultured stem cell proteome studied in an animal model of acetaminophen-induced acute liver failure. Mol Biol Rep. 2019;46(3):3101\u201312.","journal-title":"Mol Biol Rep"},{"key":"1895_CR98","first-page":"9156560","volume":"2018","author":"L Chen","year":"2018","unstructured":"Chen L, Zhang J, Yang L, Zhang G, Wang Y, Zhang S. The effects of conditioned medium derived from mesenchymal stem cells cocultured with hepatocytes on damaged hepatocytes and acute liver failure in rats. Stem Cells Int. 2018;2018:9156560.","journal-title":"Stem Cells Int"},{"issue":"4","key":"1895_CR99","first-page":"1543","volume":"9","author":"CK Sun","year":"2017","unstructured":"Sun CK, Chen CH, Chang CL, Chiang HJ, Sung PH, Chen KH, Chen YL, Chen SY, Kao GS, Chang HW, Lee MS, Yip HK. Melatonin treatment enhances therapeutic effects of exosomes against acute liver ischemia-reperfusion injury. Am J Transl Res. 2017;9(4):1543\u201360.","journal-title":"Am J Transl Res"},{"issue":"6","key":"1895_CR100","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654\u20139.","journal-title":"Nat Cell Biol"},{"key":"1895_CR101","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","volume":"93","author":"L Chen","year":"2018","unstructured":"Chen L, Lu FB, Chen DZ, Wu JL, Hu ED, Xu LM, Zheng MH, Li H, Huang Y, Jin XY, Gong YW, Lin Z, Wang XD, Chen YP. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38\u201346.","journal-title":"Mol Immunol"},{"issue":"10","key":"1895_CR102","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, Zhang Q, Cai X, Li F, Ma Z, Xu M, Lu L. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21(10):2491\u2013502.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"1895_CR103","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mt.2015.44","volume":"23","author":"S Rani","year":"2015","unstructured":"Rani S, Ryan AE, Griffin MD, Ritter T. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther. 2015;23(5):812\u201323.","journal-title":"Mol Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01895-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T03:37:19Z","timestamp":1723520239000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01895-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01895-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}